Research reveals platinum nanoparticles influence biological activity of daunorubicin, suggesting new drug formulations.
Platinum nanoparticles (PtNPs) of distinct sizes (5, 30, 50 and 70 nm) have been shown to interact with daunorubicin (DAU), leading to the formation of aggregates. The observed interactions influence DAU's biological activity.
No takes yet. Share an insight, caveat, or question.
Zakrzewski et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: